Serum 25-hydroxyvitamin D and the risk of ovarian cancer

European Journal of Cancer

Volumn 46, Issue 2, 2010, Pages 364-369

  Toriola, Adetunji T ^a,b   Surcel, Helja Marja ^a   Agborsangaya, Calypse ^b   Grankvist, Kjell ^c   Tuohimaa, Pentti ^d   Toniolo, Paolo ^e   Lukanova, Annekatrin ^f   Pukkala, Eero ^b,g   Lehtinen, Matti ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c UMEÅ UNIVERSITY   (Sweden)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g FINNISH CANCER REGISTRY   (Finland)

Author keywords

25 Hydroxyvitamin D; Nested case control; Ovarian cancer; Population based; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FINLAND; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; OVARY CANCER; PARITY; POPULATION RESEARCH; PREGNANT WOMAN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FINLAND; HUMANS; OVARIAN NEOPLASMS; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 72449146857     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.08.002     Document Type: Article

References (32)

1. Barnes M.N., Grizzle W.E., Clinton J.G., and Patridge E.E. Paradigms for primary prevention of ovarian carcinoma. CA Cancer J Clin 52 (2002) 216-225
2. Runnebaum I.G., and Stickeler E. Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol 127 (2001) 73-79
3. Freedman D.M., Dosemeci M., and McGlynn K. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med 59 (2002) 257-262
4. Grant W.B. An estimate of premature cancer mortality in the US due to inadequate doses of solar ultraviolet-B radiation. Cancer 59 (2002) 257-262
5. Lefkowitz E.S., and Garland C.F. Sunlight, Vitamin D and ovarian cancer mortality rates in US women. Int J Epidemiol 23 (1994) 1133-1136
6. Grant W.B. Ecological studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res 164 (2003) 371-377
7. Mizoue T. Ecological studies of solar radiation and cancer mortality in Japan. Health Phys 87 (2004) 532-538
8. Robsahm T.E., Trelti S., Dahlback A., and Moan J. Vitamin D3 from sunlight may improve the prognosis of breast, colon, and prostate cancer (Norway). Cancer Causes Control 15 (2004) 149-158
9. Garland C.F., Morh S.B., Gorham E.D., Grant W.B., and Garland F.C. Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer. Am J Prev Med 31 6 (2006) 512-514
10. Tuohimaa P., Pukkala E., Scelo G., et al. Dose solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer 43 (2007) 1701-1712
11. Bidoli E., La Vecchia C., Talamani R., et al. Micronutrients and ovarian cancer: a case-control study in Italy. Ann Oncol 12 (2001) 1589-1593
12. Salazar-Martinez E., Lacano-Ponce E.C., Gonzalez Lira-Lira G., Escudero-De los Rios P., and Hernandez-Avila M. Nutritional determinants of epithelial ovarian cancer risk: a case-control study in Mexico. Oncology 63 (2002) 151-157
13. Gerkinger J.M., Hunter D.J., Spiegelman D., et al. Diary products and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 15 (2006) 364-372
14. Goodman M.T., Wu A.H., Tung K.H., et al. Association of diary products, lactose, and calcium with the risk of ovarian cancer. Am J Epidemiol 156 (2002) 148-157
15. Tworoger S.S., Lee I.-M., Buring J.E., Rosner B., Hollis B.W., and Hankinson S.E. Plasma 25-hydroxyvitamin D and 1, 25 dihydroxyvitamin D and the risk of incident ovarian cancer. Cancer Epidemiol Biomarkers Prev 16 (2007) 783-788
16. Giovanucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16 (2005) 83-95
17. Ahonen M.H., Zhuang Y.H., Aine R., Ylikomi T., and Tuohimaa P. Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands. Int J Cancer 86 (2000) 40-46
18. Agic A., Xu H., Altgassen C., et al. Relative expression of 1, 25-dihydroxyvitamin D3 receptor, vitamin D1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin 25-hydroxylase in endometriosis and gynaecological cancers. Reprod Sci 14 (2007) 486-497
19. Norman A.W. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88 Suppl. (2008) 491s-499s
20. Koskela P., Antilla T., Bjørge T., et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 85 (2000) 35-39
21. Teppo L., Pukkala E., and Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 33 (1994) 365-369
22. Hollick M.F. Vitamin D deficiency. N Engl J Med 357 (2007) 266-281
23. Vieth R., Bischoff-Ferrari H., Boucher B.J., et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 85 (2007) 649-650
24. Dawson-Hughes B., Heaney R.P., Holick M.F., Lips P., Meunier P.J., and Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 16 (2005) 713-716
25. Miettinen S., Ahonen M.H., Lou Y.-.L., et al. Role of 24-hydroxylase in vitamin D3 growth response of OVCAR-3 ovarian cancer cells. Int J Cancer 108 (2004) 367-373
26. Rashid S.F., Mountford J.C., Gombart A.F., and Campbell M.J. 1 alpha, 25-dihydroxyvitamin D(3) displays divergent growth effects in both normal and malignant cells. Steroids 66 (2001) 433-440
27. Chen V.W., Ruiz B., Killeen J.L., et al. Pathology and classification of ovarian tumours. Cancer 97 (2003) 2631-2642
28. Harris S.S., and Dawson-Hughes B. The association of oral contraceptive use with plasma 25-hydroxyvitamin D levels. J Am Coll Nutr 17 3 (1998) 282-284
29. Thane C.W., Bates C.J., and Prentice A. Oral contraceptives and nutritional status in adolescent British girls. Nutr Res 22 (2002) 449-462
30. Collaborative Group on Epidemiological Studies of Ovarian Cancer, Beral V., Doll R., Hermon C., Peto R., and Reeves G. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls. Lancet 371 9609 (2008) 303-314
31. Mullin G.E., and Dobs A. Vitamin D and its role in cancer and immunity: a prescription for sunlight. Nutr Clin Pract 22 (2007) 305-322
32. International Agency for Research on Cancer, World Health Organization. Vitamin D and cancer, vol. 5. IARC working group report, 2008.